WCN25-1242 UPDATE TO THE LONG-TERM SAFETY AND EFFICACY OF IPTACOPAN IN C3G: 33-MONTH EXTENSION STUDY DATA FROM PATIENTS ENROLLED IN A PHASE 2 STUDY

WCN25-1242 UPDATE TO THE LONG-TERM SAFETY AND EFFICACY OF IPTACOPAN IN C3G: 33-MONTH EXTENSION STUDY DATA FROM PATIENTS ENROLLED IN A PHASE 2 STUDY

Saved in:

Bibliographic Details
Main Authors:	Carla Nester, Ute Eisenberger, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, Maria José Soler, Junhao Liu, Matthias Meier, Nicholas JA Webb, Edwin KS Wong
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924031218
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy
by: Carla M. Nester, et al.
Published: (2025-02-01)

WCN25-2041 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY
by: Carla Nester, et al.
Published: (2025-02-01)

Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study
by: Marina Vivarelli, et al.
Published: (2024-01-01)

Cogs on Elbląg seals dating from 1242 and 1367
by: Jerzy Maik
Published: (2011-01-01)

Early Hungarian Information about the Mongol Western Campaign (1235–1242) »
by: Roman Hautala
Published: (2015-09-01)

The First Challenges of the Russian Princes to the Mongol Rulers: Years 1242–1243
by: Gorsky A.A.
Published: (2022-06-01)

WCN24-1146 SAFETY AND EFFICACY OF IPTACOPAN IN ADOLESCENT PATIENTS WITH IDIOPATHIC (PRIMARY) IMMUNE-COMPLEX-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)
by: Nicholas Webb, et al.
Published: (2024-04-01)

WCN24-750 ASSESSMENT OF DRUG INTERACTIONS WITH IPTACOPAN
by: Robert Schmouder, et al.
Published: (2024-04-01)

WCN24-555 PHARMACOKINETICS OF SINGLE DOSES OF IPTACOPAN
by: Robert Schmouder, et al.
Published: (2024-04-01)

The Campaigns of the First Three Years of Tukultī-Ninurta’s I (1242-1206 BC)
by: Ruslan Tsakanyan
Published: (2025-03-01)

The Campaigns of the First Three Years of Tukultī-Ninurta’s I (1242-1206 BC)
by: Ruslan Tsakanyan
Published: (2025-03-01)

The Campaigns of the First Three Years of Tukultī-Ninurta’s I (1242-1206 BC)
by: Ruslan Tsakanyan
Published: (2025-03-01)

The Campaigns of the First Three Years of Tukultī-Ninurta’s I (1242-1206 BC)
by: Ruslan Tsakanyan
Published: (2025-03-01)

WCN24-748 ASSESSMENT OF THE EFFECT OF HEPATIC IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS
by: Robert Schmouder, et al.
Published: (2024-04-01)

Efficacy of iptacopan monotherapy for suboptimal response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
by: Olesya U. Klimova, et al.
Published: (2025-01-01)

The treatment of autoimmune hemolytic anemia with complement inhibitor iptacopan: a case report
by: Xiaoqing Li, et al.
Published: (2025-03-01)

Parameter Optimization of Automatic Emergency Braking System forCommercial Vehicle Based on JT/T 1242-2019
by: ZHAO Chenguang, et al.
Published: (2020-01-01)

Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency
by: Ting Wu, et al.
Published: (2025-08-01)

Corrigendum to “PREGNANCY AS A WINDOW TO CURRENT AND FUTURE KIDNEY HEALTH–AN OPPORTUNITY” [Volume 10, Issue 3, March 2025, Pages 645-649]
by: Shilpanjali Jesudason, et al.
Published: (2025-05-01)

Pregnancy as a Window to Current and Future Kidney Health–An Opportunity
by: Shilpanjali Jesudason, et al.
Published: (2025-03-01)

Successful treatment of transplant-associated thrombotic microangiopathy with iptacopan: a non-adult case study
by: Shijie Bao, et al.
Published: (2025-08-01)

THE NAIRIAN CAMPAIGN OF TUKULTĪ-NINURTA I (1242-1206 BC) IN THE CONTEXT OF THE CONQUESTS IN THE FIRST THREE YEARS OF HIS REIGN
by: Ruslan A. TSAKANYAN
Published: (2023-05-01)

Successful targeting of the alternative complement cascade with iptacopan for the treatment of IgA nephropathy: a case report
by: Leonore Ingold, et al.
Published: (2025-06-01)

WCN24-550 SINGLE DOSE OF IPTACOPAN TREATMENT RAPIDLY DESCREASES PLASMA COMPLEMENT Bb LEVELS
by: Robert Schmouder, et al.
Published: (2024-04-01)

Patient-reported improvements in paroxysmal nocturnal hemoglobinuria treated with iptacopan from 2 phase 3 studies
by: Antonio M. Risitano, et al.
Published: (2025-04-01)

Effectiveness of Iptacopan Versus C5 Inhibitors in Complement Inhibitor‐Naive Patients With Paroxysmal Nocturnal Haemoglobinuria
by: Matthew Holt, et al.
Published: (2025-06-01)

Enrollment of women in STEM
by: Mariana ROBU
Published: (2020-12-01)

Chapter 33: Parsley Production in Florida
by: George J. Hochmuth, et al.
Published: (2019-05-01)

Chapter 33: Parsley Production in Florida
by: George J. Hochmuth, et al.
Published: (2019-05-01)

WCN25-2765 PPAIRENTS: PREDICT AND PAIRS EDUCATIONAL AND NEURODEVELOPMENTAL TARGETS IN OFFSPRING SURVEY
by: Kate Bramham, et al.
Published: (2025-02-01)

Associations between enroller demographics and participant enrollment into an emergency department-based cancer prevention trial
by: Ivana-Re Baldie, et al.
Published: (2025-06-01)

WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
by: Vlado Perkovic, et al.
Published: (2024-04-01)

O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment
by: Müge Sak, et al.
Published: (2025-04-01)

WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY
by: Dmitrij Kollins, et al.
Published: (2025-02-01)

WCN25-716 EFFECT OF IPTACOPAN ON PROTEINURIA AND COMPLEMENT BIOMARKERS IN IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE PHASE 3 APPLAUSE-IgAN STUDY
by: Dmitrij Kollins, et al.
Published: (2025-02-01)

Comparing the Social Networks of Students Enrolled in Inclusive Postsecondary Education Programs and their Peers Enrolled in Traditional College Programs
by: Jennifer Bumble, et al.
Published: (2025-04-01)

Corrigendum: O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment
by: Müge Sak, et al.
Published: (2025-06-01)

Severe hemolysis flare of refractory autoimmune hemolytic anemia with positive complement component C3d responsive to Iptacopan with cyclophosphamide and prednisone: a case report
by: Yawen Zhang, et al.
Published: (2025-12-01)

An instructional emperor pigeon optimization (IEPO) based DeepEnrollNet for university student enrolment prediction and retention recommendation
by: Sunil Kumar Sharma
Published: (2024-12-01)

ENROLLMENT COMPETITION, ADMISSION AND GRADUATION: REGULARITY OF INTERCONNECTION
by: Victoria F. Pugach
Published: (2016-12-01)